Skip to Main Content
Skip Nav Destination

Synthetic biology is rapidly growing to meet the demand for inexpensive and sustainable resources. So far, the field has developed microbial strains producing biofuels, materials, drugs, as well as new tools for clinical diagnostics and gene therapy. Although rich in potential, synthetic biology still requires development – particularly in the area of automation. The price and footprint of commercially available automation equipment is restrictive to research and these tools are often not tailored to complete the entire workflow of a given project. In response to this, droplet microfluidic platforms are being developed to expedite synthetic biology. In particular, droplet microfluidic devices have been developed to assemble and transform DNA, perform high-throughput screening assays and perform directed evolution. By consolidating these capabilities and pairing them with design automation and analysis tools, droplet microfluidics will launch a new generation of synthetic biology.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal